Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133+ cells-implications for stem cell therapies in regenerative medicine

Stem Cells and Development

Volumn 22, Issue 3, 2013, Pages 422-430

  Ratajczak, Janina ^a   Kucia, Magda ^a   Mierzejewska, Kasia ^a,b   Marlicz, Wojciech ^b   Pietrzkowski, Zbigniew ^c   Wojakowski, Wojciech ^d   Greco, Nicholas J ^a   Tendera, Michal ^d   Ratajczak, Mariusz Z ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c Applied BioClinical Inc   (United States)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 8; MESSENGER RNA; SOMATOMEDIN C; STEM CELL FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD; CELL SEPARATION; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; CHEMOTAXIS; CULTURE MEDIA, CONDITIONED; FETAL BLOOD; FLOW CYTOMETRY; GLYCOPROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, SCID; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; PEPTIDES; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSCRIPTOME;

EID: 84872719779     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0268     Document Type: Article

References (28)

1. Lasala GP and JJ Minguell. (2009). Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocardial infarction. Heart Lung Circ 18: 171-180.
2. Tendera M, W Wojakowski, W Ruzy11o, L Chojnowska, C Kepka, W Tracz, et al. (2009). Intracoronary infusion of bone marrow-derived selected CD34 + CXCR4 + cells and nonselected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 30:1313-1321.
3. Tongers J, DW Losordo and U Landmesser. (2011). Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 10: 1197-1206.
4. Ratajczak MZ, M Kucia, T Jadczyk, NJ Greco, W Wojakowski, M Tendera and J Ratajczak. (2012). Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 26:1166-1173.
5. Majka M, A Janowska-Wieczorek, J Ratajczak, K Ehrenman, Z Pietrzkowski, MA Kowalska, et al. (2001). Numerous growth factors, cytokines, and chemokines are secreted by human CD34( + ) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97:3075-3085.
6. Janowska-Wieczorek A, M Majka, J Ratajczak and MZ Ratajczak. (2001). Autocrine/paracrine mechanisms in human hematopoiesis. Stem Cells 19:99-107.
7. Sahoo S, E Klychko, T Thorne, S Misener, KM Schults, M Millay, et al. (2011). Exosomes from human CD34 + stem cells mediate their proangiopoietic paracrine activity. Circ Res 109:724-728.
8. Lataillade JJ, D Clay, P Bourin, F Hérodin, C Dupuy, C Jasmin, et al. (2002). Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34( + ) cells: evidence for an autocrine/paracrine mechanism. Blood 99:1117-1129.
9. Ratajczak J, M Wysoczynski, F Hayek, Janowska-Wieczorek and MZ Ratajczak. (2006). Membrane-derived microvesicles (MV): important and underappreciated mediators of cell to cell communication. Leukemia 20:1487-1495.
10. Quesenberry PJ, MS Dooner and JM Aliotta. (2010). Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles. Exp Hematol 38:581-592.
11. Camussi G, MC Deregibus and C Tetta. (2010). Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information. Curr Opin Nephrol Hypertens 19:7-12.
12. Ratajczak J, J Kijowski, M Majka, K Jankowski, R Reca and MZ Ratajczak. (2003). Biological significance of the different erythropoietic factors secreted by normal human early erythroid cells. Leuk Lymphoma 44:767-774.
13. Majka M, J Kijowski, E Lesko, J Goźdizk, B Zupanska and MZ Ratajczak. (2007). Evidence that platelet-derived micro-vesicles may transfer platelet-specific immunoreactive antigens to the surface of endothelial cells and CD34 + hematopoietic stem/progenitor cells-implication for the pathogenesis of immune thrombocytopenias. Folia Histochem Cytobiol 45:27-32.
14. Janowska-Wieczorek A, M Majka, L Marquez-Curtis, JA Wertheim, AR Turner and MZ Ratajczak. (2002). Bcr-ablpositive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia 16:1160-1166.
15. Ratajczak J, K Miekus, M Kucia, J Zhang, R Reca, P Dvorak, et al. (2006). Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20:847-856.
16. Ratajczak MZ, EK Zuba-Surma, M Wysoczynski, W Wan, J Ratajczak, W Wojakowski, et al. (2008). Hunt for pluripotent stem cell-regenerative medicine search for almighty cell. J Autoimmun 30:151-162.
17. Borlongan CV. (2011). Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all! Leukemia 25:1674-1686.
18. Staal FJ, C Baum, C Cowan, E Dzierzak, S Hacein-Bey-Abina, S Karlsson, et al. (2011). Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications. Leukemia 25:1095-1102.
19. Murry CE, MH Soonpaa, H Reinecke, H Nakajima, HO Nakajima, M Rubart, et al. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668.
20. Castro RF, KA Jackson, MA Goodell, CS Robertson, H Liu and HD Shine. (2002). Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 297:1299.
21. Miraglia S, W Godfrey, AH Yin, K Atkins, R Warnke, JT Holden, RA Bray, EK Waller and DW Buck. (1997). A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90: 5013-5021.
22. Ratajczak J, E Zuba-Surma, I Klich, R Liu, M Wysoczynski, N Greco, M Kucia, MJ Laughlin and MZ Ratajczak. (2011). Hematopoietic differentiation of umbilical cord blood-derived very small embryonic/epiblast-like stem cells. Leukemia 25:1278-1285.
23. Meregalli M, A Farini, M Belicchi and Y Torrente. (2010). CD133( + ) cells isolated from various sources and their role in future clinical perspectives. Expert Opin Biol Ther 10:1521-1528.
24. Aliotta JM, FM Sanchez-Guijo, GJ Dooner, KW Johnson, MS Dooner, KA Greer, D Greer, et al. (2007). Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 25: 2245-2256.
25. Herrera MB, V Fonsato, S Gatti, MC Deregibus, A Sordi, D Cantarella, et al. (2010). Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 14:1605-1618.
26. Limaye V. (2008). The role of sphingosine kinase and sphingosine-1- phosphate in the regulation of endothelial cell biology. Endothelium 15:101-112.
27. Ratajczak MZ, CH Kim, A Abdel-Latif, G Schneider, M Kucia, AJ Morris, et al. (2012). A novel perspective on stem cell homing and mobilization-review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients. Leukemia 26:63-72.
28. Baj-Krzyworzeka M, M Majka, D Pratico, J Ratajczak, G Vilaire, J Kijowski, et al. (2002). Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 30:450-459.